{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T22:31:07Z","timestamp":1784413867167,"version":"3.55.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T00:00:00Z","timestamp":1637798400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T00:00:00Z","timestamp":1637798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>This study investigated the outcomes and major adverse cardiovascular events (MACEs) incurred by acute myocardial infarction (AMI) patients comorbiding with hypertension and hyperhomocysteinemia (HHcy) during hospitalization and 1-year follow-up. 648 consecutive AMI patients were divided into four categories: (1) hypertension with Hcy\u2009\u2265\u200915\u00a0\u00b5mol\/L; (2) hypertension with Hcy\u2009&lt;\u200915\u00a0\u00b5mol\/L; (3) no-hypertension with Hcy\u2009\u2265\u200915\u00a0\u00b5mol\/L; (4) no-hypertension with Hcy\u2009&lt;\u200915\u00a0\u00b5mol\/L. Information taken from these case files included gender, past medical history, vital signs, laboratory examination, electrocardiogram, coronary angiography, cardiac ultrasound, and medicine treatment. The primary endpoints were duration of coronary care units (CCU) stay, duration of in-hospital stay, and MACEs during follow-up. Our data show that hypertension and HHcy have a synergistic effect in AMI patients, AMI comorbiding with hypertension and HHcy patients had more severe multi-coronary artery disease and more frequent non-culprit coronary lesions complete clogging, had a higher prevalence of pro-brain natriuretic peptide, and significant decreases in the left ventricular ejection fraction. These patients had significant increases in the duration of CCU stay and in-hospital stay, had significant increase in the rate of MACEs, had significant decreases in the survival rate during follow-up.<\/jats:p>","DOI":"10.1038\/s41598-021-02340-w","type":"journal-article","created":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T06:08:02Z","timestamp":1637820482000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["The outcomes of acute myocardial infarction patients comorbidity with hypertension and hyperhomocysteinemia"],"prefix":"10.1038","volume":"11","author":[{"given":"Jumei","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zilin","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,25]]},"reference":[{"key":"2340_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1475-2891-3-4","volume":"3","author":"MR Hayden","year":"2004","unstructured":"Hayden, M. R. & Tyagi, S. C. Homocysteine and reactive oxygen species in metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: The pleiotropic effects of folate supplementation. Nutr. J. 3, 4 (2004).","journal-title":"Nutr. J."},{"key":"2340_CR2","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1056\/NEJM199804093381507","volume":"338","author":"GN Welch","year":"1998","unstructured":"Welch, G. N. & Loscalzo, J. Homocysteine and atherothrombosis. N. Engl. J. Med. 338, 1042\u20131050 (1998).","journal-title":"N. Engl. J. Med."},{"key":"2340_CR3","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1053\/euhj.2001.2962","volume":"23","author":"G Schnyder","year":"2002","unstructured":"Schnyder, G. et al. Association of plasma homocysteine with restenosis after percutaneous coronary angioplasty. Eur. Heart J. 23, 726\u201333 (2002).","journal-title":"Eur. Heart J."},{"key":"2340_CR4","doi-asserted-by":"publisher","first-page":"352","DOI":"10.7326\/0003-4819-131-5-199909070-00006","volume":"131","author":"AG Bostom","year":"1999","unstructured":"Bostom, A. G. et al. Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons: The Framingham Study. Ann. Intern. Med. 131, 352\u20135 (1999).","journal-title":"Ann. Intern. Med."},{"key":"2340_CR5","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1161\/01.STR.0000152336.71224.21","volume":"36","author":"M Fisher","year":"2005","unstructured":"Fisher, M. et al. Carotid plaque pathology: Thrombosis, ulceration, and stroke pathogenesis. Stroke 36, 253\u20137 (2005).","journal-title":"Stroke"},{"key":"2340_CR6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1475-2891-14-6","volume":"14","author":"P Ganguly","year":"2015","unstructured":"Ganguly, P. & Alam, S. F. Role of homocysteine in the development of cardiovascular disease. Nutr. J. 14, 6 (2015).","journal-title":"Nutr. J."},{"key":"2340_CR7","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1001\/jama.1997.03540460039030","volume":"277","author":"IM Graham","year":"1997","unstructured":"Graham, I. M. et al. Plasma homocysteine as a risk factor for vascular disease. The European concerted action project. JAMA 277, 1775\u201381 (1997).","journal-title":"JAMA"},{"key":"2340_CR8","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1001\/jama.1995.03530130055028","volume":"274","author":"CJ Boushey","year":"1995","unstructured":"Boushey, C. J. et al. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 274, 1049\u201357 (1995).","journal-title":"JAMA"},{"key":"2340_CR9","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1056\/NEJM199707243370403","volume":"337","author":"O Nygard","year":"1997","unstructured":"Nygard, O. et al. Plasma homocysteine levels and mortality in patients with coronary artery disease. N. Engl. J. Med. 337, 230\u201369 (1997).","journal-title":"N. Engl. J. Med."},{"key":"2340_CR10","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1001\/archinte.163.16.1933","volume":"163","author":"S Matetzky","year":"2003","unstructured":"Matetzky, S. et al. Association of elevated homocysteine levels with a higher risk of recurrent coronary events and mortality in patients with acute myo-cardial infarction. Arch. Intern. Med. 163, 1933\u20137 (2003).","journal-title":"Arch. Intern. Med."},{"key":"2340_CR11","doi-asserted-by":"publisher","first-page":"e1464","DOI":"10.1097\/MJT.0000000000000130","volume":"23","author":"Y Ma","year":"2016","unstructured":"Ma, Y. et al. Correlation between hyperhomocysteinemia and outcomes of patients with acute myocardial infarction. Am J. Ther. 23, e1464\u2013e8 (2016).","journal-title":"Am J. Ther."},{"key":"2340_CR12","first-page":"1467","volume":"10","author":"F Zhenhong","year":"2015","unstructured":"Zhenhong, F. et al. Hyperhomocysteinemia is an independent predictor of long-term clinical outcomes in Chinese octogenarians with acute coronary syndrome. Clin. Interv. Aging 10, 1467\u201374 (2015).","journal-title":"Clin. Interv. Aging"},{"key":"2340_CR13","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1056\/NEJMe1309383","volume":"369","author":"L Mauri","year":"2013","unstructured":"Mauri, L. Nonculprit lesions\u2013innocent or guilty by association. N. Engl. J. Med. 369, 1166\u20131167 (2013).","journal-title":"N. Engl. J. Med."},{"key":"2340_CR14","first-page":"299","volume":"13","author":"H Tianwen","year":"2016","unstructured":"Tianwen, H. et al. Homocysteine is associated with the progression of non-culprit coronary lesions in elderly acute coronary syndrome patients after percutaneous coronary intervention. J. Geriatr. Cardiol. 13, 299\u2013305 (2016).","journal-title":"J. Geriatr. Cardiol."},{"key":"2340_CR15","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","volume":"360","author":"S Lewington","year":"2002","unstructured":"Lewington, S. et al. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360, 1903\u201313 (2002).","journal-title":"Lancet"},{"key":"2340_CR16","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/S0735-1097(02)01737-0","volume":"39","author":"AM Richards","year":"2002","unstructured":"Richards, A. M. et al. Antecedent hypertension and heart failure after myocardial infarction. J. Am. Coll. Cardiol. 39, 1182\u20138 (2002).","journal-title":"J. Am. Coll. Cardiol."},{"key":"2340_CR17","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jns.2010.07.013","volume":"298","author":"A Towfigurehi","year":"2010","unstructured":"Towfigurehi, A., Markovic, D. & Ovbiagele, B. Pronounced association of elevated serum homocysteine with stroke in subgroups of individuals: A nationwide study. J. Neurol. Sci. 298, 153\u2013157 (2010).","journal-title":"J. Neurol. Sci."},{"key":"2340_CR18","doi-asserted-by":"publisher","first-page":"477","DOI":"10.3390\/ijerph13050477","volume":"13","author":"Zh Qing","year":"2016","unstructured":"Qing, Zh. et al. H-type hypertension and C reactive protein in recurrence of ischemic stroke. Int. J. Environ. Res. Public Health 13, 477 (2016).","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"2340_CR19","doi-asserted-by":"publisher","first-page":"424","DOI":"10.3109\/10641963.2015.1116547","volume":"38","author":"Z Chen","year":"2016","unstructured":"Chen, Z. et al. H-type hypertension is an important risk factor of carotid atherosclerotic plaques. Clin. Exp. Hypertens. 38, 424\u20138 (2016).","journal-title":"Clin. Exp. Hypertens."},{"key":"2340_CR20","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1093\/ajh\/hpu248","volume":"28","author":"C Catena","year":"2015","unstructured":"Catena, C. et al. Elevated homocysteine levels are associated with the metabolic syndrome and cardiovascular events in hypertensive patients. Am. J. Hypertens. 28, 943\u201350 (2015).","journal-title":"Am. J. Hypertens."},{"key":"2340_CR21","doi-asserted-by":"crossref","unstructured":"Rodrigo R, Passalacqua W, Araya J. et al. Homocysteine and essential hypertension. J Clin Pharmacol. 43, 1299\u2013306 (2003).","DOI":"10.1177\/0091270003258190"},{"issue":"Suppl","key":"2340_CR22","first-page":"16","volume":"50","author":"GS Sainani","year":"2002","unstructured":"Sainani, G. S. & Sainani, R. Homocysteine and its role in the pathogenesis of atherosclerotic vascular disease. J. Assoc. Phys. India 50(Suppl), 16\u201323 (2002).","journal-title":"J. Assoc. Phys. India"},{"key":"2340_CR23","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1093\/eurheartj\/ehs184","volume":"33","author":"K Thygesen","year":"2012","unstructured":"Thygesen, K. et al. Third universal definition of myocardial infarction. Eur. Heart J. 33, 2551\u201367 (2012).","journal-title":"Eur. Heart J."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-02340-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-02340-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-02340-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T12:46:23Z","timestamp":1670071583000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-02340-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,25]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["2340"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-02340-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-567667\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,25]]},"assertion":[{"value":"27 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22936"}}